PROCEPT BioRobotics Corporation (PRCT)

Import this data to Google Sheets with:

=jivedata("PRCT","financials")

Full statements spill as a table. For one cell: =jivedata("PRCT","Revenue") or =jivedata("PRCT","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.

PROCEPT BioRobotics Corporation

PRCT • CIK 0001588978

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Revenue from Contract with Customer, Excluding Assessed Tax	$136,191	$224,498	$308,054	$337,341
Cost of Revenue	$65,142	$87,399	$111,828	$120,695
Gross Profit	$71,049	$137,099	$196,226	$216,646
Operating Income (Loss)	$-109,170	$-96,614	$-103,859	$-114,229
InterestExpenseNonoperating	—	$4,184	$3,586	$3,473
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest	—	—	$-95,382	$-109,603
Income Tax Expense (Benefit)	$0	$0	$190	$152
Net Income (Loss) Attributable to Parent	$-105,897	$-91,413	$-95,572	$-109,755
Comprehensive Income (Loss), Net of Tax, Attributable to Parent	$-105,807	$-91,383	$-95,649	$-109,589
Research and Development Expense	$48,446	$62,298	$71,277	$78,810
Selling, General and Administrative Expense	$131,773	$171,415	$228,808	$252,065
Operating Expenses	$180,219	$233,713	$300,085	$330,875
Weighted Average Number of Shares Outstanding, Basic	47,255,000	52,125,000	55,544,000	57,152,000
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent	—	—	$-77	$166
Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax, Portion Attributable to Parent	$90	$30	$0	$0

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Cash and Cash Equivalents, at Carrying Value	$257,222	$333,725	$286,503	$227,914
Accounts Receivable, after Allowance for Credit Loss, Current	$48,376	$83,496	$83,533	$107,606
Restricted Cash, Noncurrent	$3,038	$3,038	$3,038	$3,038
Inventory, Net	$39,756	$56,168	$70,694	$77,061
Property, Plant and Equipment, Net	$28,748	$26,709	$30,399	$31,832
Prepaid Expense and Other Assets, Current	$5,213	$8,453	$9,648	$7,704
Operating Lease, Right-of-Use Asset	$20,241	$18,941	$17,538	$16,773
Assets, Current	$350,567	$481,842	$450,378	$420,285
Intangible Assets, Net (Including Goodwill)	$1,204	$932	$709	$571
Other Assets, Noncurrent	$919	$2,555	$6,019	$6,853
Assets	$404,717	$534,017	$508,081	$479,352
Long-term Debt, Excluding Current Maturities	$51,339	$51,472	$51,615	$51,715
Operating Lease, Liability, Noncurrent	$26,182	$26,868	$24,654	$23,280
Other Liabilities, Noncurrent	$517	$324	$147	$91
Liabilities	$123,965	$131,797	$142,211	$139,282
Accounts Payable, Current	$13,499	$10,032	$17,285	$15,069
Accrued Salaries, Current	$16,885	$21,537	$23,175	$20,443
Contract with Customer, Liability, Current	$5,656	$9,565	$13,048	$14,088
Operating Lease, Liability, Current	$1,683	$1,910	$2,214	$2,505
Derivative Liability, Current	$1,886	$2,000	$0	$0
Other Liabilities, Current	$6,318	$8,089	$10,073	$12,091
Liabilities, Current	$45,927	$53,133	$65,795	$64,196
Preferred Stock, Value, Issued	$0	$0	$0	$0
Additional Paid in Capital	$735,240	$948,091	$1,007,390	$1,040,104
Accumulated Other Comprehensive Income (Loss), Net of Tax	$84	$114	$37	$22
Retained Earnings (Accumulated Deficit)	$-454,572	$-545,985	$-641,557	$-700,056
Stockholders' Equity Attributable to Parent	$280,752	$402,220	$365,870	$340,070
Preferred Stock, Shares Authorized	10,000,000	10,000,000	10,000,000	10,000,000
Preferred Stock, Shares Issued	0	0	0	0
Common Stock, Shares Authorized	300,000,000	300,000,000	300,000,000	300,000,000
Common Stock, Shares, Issued	50,771,000	50,771,000	56,323,000	57,247,000

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Net Income (Loss) Attributable to Parent	$-105,897	$-91,413	$-95,572	$-109,755
Net Cash Provided by (Used in) Operating Activities	$-108,003	$-99,213	$-48,985	$-74,340
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations	—	—	$-74	$-113
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect	$34,586	$76,503	$-47,222	$-74,803
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$260,260	$336,763	$289,541	$218,975
Depreciation, Depletion and Amortization	—	$5,234	$6,390	$7,051
Payments to Acquire Property, Plant, and Equipment	$25,206	$4,409	$9,356	$10,585
Share-based Payment Arrangement, Noncash Expense	$19,134	$31,840	$47,603	$52,938
Net Cash Provided by (Used in) Investing Activities	$-25,206	$-4,409	$-9,356	$-10,585
Increase (Decrease) in Derivative Liabilities	—	$114	$0	$0
Accounts Receivable, Credit Loss Expense (Reversal)	—	—	$219	$25
Inventory Write-down	$995	$1,881	$565	$679
Gain (Loss) on Extinguishment of Debt	$0	$0	$-157	$-157
Proceeds from Repayment of Loans by Employee Stock Ownership Plans	$3,610	$4,527	$6,362	$7,170
Proceeds from Stock Options Exercised	$2,480	$11,075	$4,831	$3,065
Proceeds from Issuance of Common Stock	$161,705	$164,523	$0	$0
Net Cash Provided by (Used in) Financing Activities	$167,795	$180,125	$11,193	$10,235
Cash and Cash Equivalents, at Carrying Value	$257,222	$333,725	$286,503	$215,937
Restricted Cash and Cash Equivalents, Current	$3,038	$3,038	$3,038	$3,038
Interest Paid, Excluding Capitalized Interest, Operating Activities	$4,056	$3,970	$3,463	$3,299
Increase (Decrease) in Accounts Receivable	$33,103	$35,960	$898	$27,069
Increase (Decrease) in Inventories	$9,751	$17,235	$14,498	$10,258
Increase (Decrease) in Prepaid Expense and Other Assets	$-1,051	$3,211	$1,102	$225
Increase (Decrease) in Other Operating Assets	$868	$1,637	$2,895	$2,565
Increase (Decrease) in Accounts Payable	$5,789	$-2,152	$6,648	$3,828
Increase (Decrease) in Accrued Salaries	$3,438	$4,652	$1,590	$4,112
Increase (Decrease) in Interest Payable, Net	$125	$134	$142	$190
Increase (Decrease) in Contract with Customer, Liability	$3,317	$3,716	$3,306	$4,067
IncreaseDecreaseInOperatingLeaseLiability	$4,989	$2,596	$0	$0
Increase (Decrease) in Other Operating Liabilities	$-1,149	$1,771	$1,868	$2,278
Capital Expenditures Incurred but Not yet Paid	$1,863	$348	$969	$477

Loading financial statements…

Import this data to Google Sheets with:

=jivedata("PRCT","financials")

Full statements spill as a table. For one cell: =jivedata("PRCT","Revenue") or =jivedata("PRCT","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.